A complication ofcapillary haemangiomas is ulceration, which may arise after trauma and/or infection. Until recently, conservative management was the rule. However, the recent advent of the pulsed dye laser has revolutionised the treatment of vascular birthmarks and provided a new tool for the management of capillary haemangiomas. Thirteen cases of ulcerated capillary haemangiomas referred to our department were reviewed; five were treated conservatively and eight were treated with the laser. Those treated with the laser had all failed conservative management and healed completely within one to four weeks. Remarkably rapid alleviation of pain was achieved. For those haemangiomas around the mouth and perineum, laser treatment enabled early restoration ofnormal feeding, micturition, and defaecation.
Capillary haemangiomas are common birthmarks affecting around one in 20 infants. They appear at or soon after birth and follow a well defined course characterised by progressive enlargement until 3 to heal, cause pain and distress to the child, and can result in scarring. In the past decade, a number of treatment alternatives, such as argon, neodymium:yttrium aluminium garnet (Nd:YAG) or carbon dioxide lasers, cryosurgery and surgical excision, have been put forward but failed to prove beneficial other than in isolated cases. 2 The recent availability of the 585 nm flashlamp pulsed dye laser has, however, revolutionised the treatment of vascular birthmarks. Due to its unique capacity of selectively damaging cutaneous blood vessels to a depth of 1 2 mm, it is now the treatment of choice for port wine stains and telangiectases.3 4 When handled correctly, adverse effects are negligible.5
The pulsed dye laser has also been reported to effectively treat ulcerated haemangiomas.6 7 We have critically reviewed all children with ulcerated haemangiomas referred to our department over the past six months, some of whom were treated conservatively and others who have received laser treatment, in order to define a strategy of management. Ulceration of the vulva of the patient with neonatal haemangiomatosis (patient 10; fig 1) occurred despite combined treatment with systemic prednisone and recombinant interferon alfa, and healed within one week after laser treatment.
Patients and methods
A second treatment was necessary in two patients. Patient 1 had an extensive haemangioma over the scalp and face and was treated early enough to prevent further growth of the haemangioma. The second treatment was followed by signs of regression which, at 7 weeks of age, is a remarkable result. A second laser session was required for patient 2 due to a recurrence of the ulceration in an adjacent and previously untreated area of haemangioma.
Discussion
The appearance of ulceration in capillary haemangiomas presents a difficult management problem. Superinfection is frequent and may lead to septicaemia. Ulcerated lesions are often painful and need daily cleaning and dressings for weeks or months. Moreover, the outcome is knowingly poor with frequent scarring and possibly marked disfigurement. It is therefore essential to treat ulcerated capillary haemangiomas as quickly and as efficiently as possible.
The availability of the pulsed dye laser now provides a recognised alternative to conservative management.67 In our series, it has proved to be reliable, allowing rapid healing in all cases that were refractory to conservative treatment.
Uncomplicated ulcerated haemangiomas can be managed conservatively. After an initial assessment including microbiological studies, What then is the current role of laser treatment in the management of capillary haemangiomas? It can be regarded as having three major indications. Firstly, it has been proposed that early laser treatment of newly arising capillary haemangiomas, at the age of 3 to 6 weeks, would prevent further growth.9
Indeed, the haemangioma of patient 7 in this series showed signs of regression after two laser sessions and we have seen small capillary haemangiomas regress after only one treatment in a premature baby (unpublished observation by the authors). Secondly, as shown in this paper, laser treatment is valuable in the management of ulcerated lesions. Thirdly, laser treatment is the treatment of choice for residual telangiectases after the haemangioma has spontaneously resolved.
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